Home HEALTH ADA 2019: Positive safety results for oral semaglutide – The Pharma Letter

ADA 2019: Positive safety results for oral semaglutide – The Pharma Letter

by admin2 admin2
20 views

Become a Subscriber

What you get

Unlimited access to The Pharma Letter site for a whole year


Only £77 per month or £820 per year

alt

  • No-limits access to our site with up-to-the minute news
  • Personalised news and email alerts
  • Online discussion forums and Q&A section
  • RSS news feeds that you can add to your favourite reader, or website
  • Daily news email alert, with the breaking news stories and news roundup

Click here to subscribe

“Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed”

Nigel Brooksby, Chairman, Sanofi aventis UK Ltd

Read More

You may also like

Leave a Comment